Request Demo
Last update 24 Mar 2025
BGB-30813
Last update 24 Mar 2025
Overview
Basic Info
Drug Type Chemical drugs |
Synonyms BGB 30813, BGB30813 |
Target |
Action inhibitors |
Mechanism DGKζ inhibitors(diacylglycerol kinase zeta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with BGB-30813CTIS2023-503996-38-00
- BGB-A317-30813-101
NCT05904496
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the DGKζ Inhibitor BGB-30813, Alone or in Combination With the Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced or Metastatic Solid Tumors
100 Clinical Results associated with BGB-30813
Login to view more data
100 Translational Medicine associated with BGB-30813
Login to view more data
100 Patents (Medical) associated with BGB-30813
Login to view more data
100 Deals associated with BGB-30813
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 19 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Australia | 19 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 19 Jul 2023 | |
| Endometrial Carcinoma | Phase 1 | United States | 19 Jul 2023 | |
| Endometrial Carcinoma | Phase 1 | China | 19 Jul 2023 | |
| Endometrial Carcinoma | Phase 1 | Australia | 19 Jul 2023 | |
| Endometrial Carcinoma | Phase 1 | Spain | 19 Jul 2023 | |
| Esophageal Carcinoma | Phase 1 | United States | 19 Jul 2023 | |
| Esophageal Carcinoma | Phase 1 | China | 19 Jul 2023 | |
| Esophageal Carcinoma | Phase 1 | Australia | 19 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free